‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
SurgOnc Today®
Should Patients at High Risk of Peritoneal Dissemination from Gastric and Colon cancers Undergo HIPEC as an Adjuvant Therapy?
30
00:00:00
/ 00:19:56
30